Advertisement

Vitamin D and Ageing

  • Tom R. HillEmail author
  • Antoneta Granic
  • Terence J. Aspray
Chapter
Part of the Subcellular Biochemistry book series (SCBI, volume 90)

Abstract

One hundred years has passed since the discovery of vitamin D as the active component of cod-liver oil which cured the bone disease rickets. Since then our knowledge of vitamin D has expanded tremendously and has included recognition of the importance of UV radiation as a source of the vitamin as well as the discovery of the vitamin as a nutrient, a pro-hormone and a potent steroid hormone with a major role in calcium and bone metabolism. In the last 25 years or so, the discovery of the vitamin D receptor in over 30 different body tissues together with the existence of the alpha-1-hydroxylase enzyme in these tissues provided evidence of a pleiotropic role of vitamin D outside its classical role in the skeleton. These important discoveries have provided the basis for the increasing interest in vitamin D in the context of nutritional requirements for health including the prevention of chronic diseases of ageing. The recent publication of the Dietary Reference Intake report on vitamin D and calcium by the North American Institute of Medicine (IOM) is the most comprehensive report to date on the basis for setting nutritional requirements for vitamin D. This chapter will summarize the nutritional aspects of vitamin D and discuss the changes in vitamin D metabolism and requirements with ageing. It will summarize key evidence on the relationship between vitamin D status and some of the main ageing related health outcomes including bone, muscle and cognitive health as well as survival focusing on the published literature in very-old adults (those >= 85 years of age).

Keywords

Vitamin D Very-old adults Metabolism and function Nutritional requirements Epidemiology Musculoskeletal health Cognitive health Mortality 

Notes

Acknowledgements

This work did not receive external funding.

Declaration of Conflicts of Interest

Dr. Tom Hill has received industry funding from Noble Foods Ltd, Nutricia Ltd and the UK Dairy Council.

References

  1. Amer M, Qayyum R (2013) Relationship between 25-hydroxyvitamin D and all-cause and cardiovascular disease mortality. Am J Med 126:509–514CrossRefPubMedGoogle Scholar
  2. Andersen R, Mølgaard C, Skovgaard LT et al (2005) Teenage girls and elderly women living in northern Europe have low winter vitamin D status. Eur J Clin Nutr 59:533–541CrossRefPubMedGoogle Scholar
  3. Annweiler C, Schott AM, Allali G et al (2010) Association of vitamin D deficiency with cognitive impairment in older women: cross-sectional study. Neurology 74:27–32CrossRefPubMedGoogle Scholar
  4. Arabi A, Mahfoud Z, Zahed L et al (2010) Effect of age, gender and calciotropic hormones on the relationship between vitamin D receptor gene polymorphisms and bone mineral density. Eur J Clin Nutr 64(4):383–391CrossRefPubMedGoogle Scholar
  5. Aspray TJ, Francis RM (2013) What can we learn about vitamin D requirements from post-mortem data? Osteoporos Int 4(5):1769–1770CrossRefGoogle Scholar
  6. Autier P, Gandi S (2007) Vitamin D supplementation and total mortality – a meta-analysis of randomized controlled trials. Arch Intern Med 167:1730–1737CrossRefPubMedGoogle Scholar
  7. Avenell A, Gillespie WJ, Gillespie LD, O’Connell D (2009) Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Re 15(2):CD000227Google Scholar
  8. Baker MR, Peacock M, Nordin BE (1980) The decline in vitamin D status with age. Age Ageing 9:249–252CrossRefPubMedGoogle Scholar
  9. Balion C, Griffith LE, Strifler L et al (2012) Vitamin D, cognition, and dementia. Neurology 79:1397–1405CrossRefPubMedPubMedCentralGoogle Scholar
  10. Bates CJ, Carter GD, Mishra GD et al (2003) In a population study, can parathyroid hormone aid the definition of adequate vitamin D status? A study of people aged 65 years and over from the British National Diet and Nutrition Survey. Osteoporos Int 14(2):152–159CrossRefPubMedGoogle Scholar
  11. Beaudart C, Buckinx F, Rabenda V et al (2014) The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials. J Clin Endocrinol Metab 99:4336–4345CrossRefPubMedGoogle Scholar
  12. Biehl RR, Baker DH, DeLuca HF (1995) 1 alpha-hydroxylated cholecalciferol compounds act additively with microbial phytase to improve phosphorus, zinc and manganese utilization in chicks fed soy-based diets. J Nutr 125:2407–2416CrossRefPubMedGoogle Scholar
  13. Bischoff HA, Borchers M, Gudat F et al (2001) In situ detection of 1,25- dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem J 33:19–24CrossRefPubMedGoogle Scholar
  14. Bischoff-Ferrari HA (2012) Relevance of vitamin D in muscle health. Rev Endocr Metab Disord 13:71–77CrossRefPubMedGoogle Scholar
  15. Bischoff-Ferrari HA, Borchers M et al (2004) Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res 19(2):265–269CrossRefPubMedGoogle Scholar
  16. Bischoff-Ferrari HA, Giovannucci E, Willett WC et al (2006) Estimation of optimal circulating concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84(1):18–28CrossRefPubMedGoogle Scholar
  17. Bischoff-Ferrari HA, Orav EJ, Dawson-Hughes B (2008) Additive benefit of higher testosterone levels and vitamin D plus calcium supplementation in regard to fall risk reduction among older men and women. Osteoporos Int 19(9):1307–1314CrossRefPubMedPubMedCentralGoogle Scholar
  18. Bischoff-Ferrari HA, Kiel DP, Dawson-Hughes B et al (2009a) Dietary calcium and circulating 25-hydroxyvitamin D status in relation to BMD among U.S. adults. J Bone Miner Res 24:935–942CrossRefPubMedGoogle Scholar
  19. Bischoff-Ferrari HA, Willett WC, Wong JB et al (2009b) Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 169:551–561CrossRefPubMedGoogle Scholar
  20. Bischoff-Ferrari HA, Shao A, Dawson-Hughes B et al (2010) Benefit-risk assessment of vitamin D supplementation. Osteoporos Int 21:1121–1132CrossRefPubMedGoogle Scholar
  21. Bischoff-Ferrari HA, Willett WC, Orav EJ et al (2012) A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med 367:40–49CrossRefPubMedGoogle Scholar
  22. Bjelakovic G, Gluud LL, Nikolova D et al (2014) Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 1:CD007470Google Scholar
  23. Boonen S, Lips P, Bouillon R et al (2007) Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab 92:1415–1423CrossRefPubMedGoogle Scholar
  24. Brannon PM (2012) Key questions in vitamin D research. Scand J Clin Lab Invest Suppl 243:154–162PubMedGoogle Scholar
  25. Bronnick K, Ehrt U, Emre M et al (2006) Attention deficits affect activities of daily living in dementia associated with Parkinson’s disease. J Neurol Neurosurg Psychiatry 77:1136–1142CrossRefPubMedPubMedCentralGoogle Scholar
  26. Bruyère O, Slomian J, Beaudart C et al (2014) Prevalence of vitamin D inadequacy in European women aged over 80 years. Arch Gerontol Geriatr 59(1):78–82CrossRefPubMedGoogle Scholar
  27. Buell JS, Scott TM, Dawson-Hughes B et al (2009) Vitamin D is associated with cognitive function in elders receiving home health services. J Gerontol A Biol Sci Med Sci 64:888–895CrossRefPubMedGoogle Scholar
  28. Bullamore JR, Wilkinson R, Gallagher JC et al (1970) Effect of age on calcium absorption. Lancet 2(7672):535–537CrossRefPubMedGoogle Scholar
  29. Cancer IARC (2008) Vitamin D and cancer/a report of the IARC working group on vitamin D. IARC, LyonGoogle Scholar
  30. Carter GD (2011) Accuracy of 25-hydroxyvitamin D assays: confronting the issues. Curr Drug Targets 12(1):19–28CrossRefPubMedGoogle Scholar
  31. Cashman KD, Wallace JM, Horigan G et al (2009) Estimation of the dietary requirement for vitamin D in free-living adults >=64 y of age. Am J Clin Nutr 89(5):1366–1374CrossRefPubMedGoogle Scholar
  32. Ceglia L, Harris SS (2013) Vitamin D and its role in skeletal muscle. Calcif Tissue Int 92:151–162CrossRefPubMedGoogle Scholar
  33. Chapuy MC, Arlot ME, Duboeuf F et al (1992) Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 327:1637–1642CrossRefPubMedGoogle Scholar
  34. Chapuy MC, Preziosi P, Maamer M et al (1997) Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 7(5):439–443CrossRefPubMedGoogle Scholar
  35. Christakos S, Hewison M, Gardner DG et al (2013) Vitamin D: beyond bone. Ann N Y Acad Sci 1287:45–58CrossRefPubMedPubMedCentralGoogle Scholar
  36. Chung M, Lee J, Terasawa T et al (2011) Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med 155:827–838CrossRefPubMedGoogle Scholar
  37. Collerton J, Davies K, Jagger C et al (2009) Health and disease in 85 year olds: baseline findings from the Newcastle 85+ cohort study. BMJ 399:b4904CrossRefGoogle Scholar
  38. Cranney A, Horsley T, O’Donnell S et al (2007) Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep) 158:1–235Google Scholar
  39. Dam TT, von Mühlen D, Barrett-Connor EL (2009) Sex-specific association of circulating vitamin D levels with physical function in older adults. Osteoporos Int 20:751–760CrossRefPubMedGoogle Scholar
  40. Darling AL, Hart KH, Macdonald HM et al (2013) Vitamin D deficiency in UK South Asian Women of childbearing age: a comparative longitudinal investigation with UK Caucasian women. Osteoporos Int 24(2):477–488CrossRefPubMedGoogle Scholar
  41. Dawson-Hughes B (2012) Circulating 25-hydroxyvitamin D and muscle atrophy in the elderly. Proc Nutr Soc 71(1):46–49CrossRefPubMedGoogle Scholar
  42. Dawson-Hughes B, Harris S, Kramich C et al (1993) Calcium retention and hormone levels in black and white women on high- and low-calcium diets. J Bone Miner Res 8:779–787CrossRefPubMedGoogle Scholar
  43. Dhesi JK, Jackson SH, Bearne LM et al (2004) Vitamin D supplementation improves neuromuscular function in older people who fall. Age Ageing 33:589–595CrossRefPubMedGoogle Scholar
  44. DIPART (Vitamin D Individual Patient Analysis of Randomized Trials) Group (2010) Patient level pooled analysis of 68,500 patients from seven major vitamin D fracture trials in US and Europe. BMJ 340:b5463CrossRefGoogle Scholar
  45. Dodds RM, Granic A, Davies K et al (2017) Prevalence and incidence of sarcopenia in the very old: findings from the Newcastle 85+ study. J Cachexia Sarcopenia Muscle 8(2):229–237CrossRefPubMedGoogle Scholar
  46. Dror Y, Giveon SM, Hoshen M et al (2013) Vitamin D levels for preventing acute coronary syndrome and mortality: evidence of a nonlinear association. J Clin Endocrinol Metab 98:2160–2167CrossRefPubMedGoogle Scholar
  47. Durazo-Arvizu RA, Dawson-Hughes B et al (2010) Three-phase model harmonizes estimates of the maximal suppression of parathyroid hormone by 25-hydroxyvitamin D in persons 65 years of age and older. J Nutr 140(3):595–599CrossRefPubMedPubMedCentralGoogle Scholar
  48. Durup D, Jørgensen HL, Christensen J et al (2012) A reverse J-shaped association of all-cause mortality with circulating 25-hydroxyvitamin D in general practice: the CopD study. J Clin Endocrinol Metab 97:2644–2652CrossRefPubMedGoogle Scholar
  49. Eastell R, Yergey AL, Vieira NE et al (1991) Interrelationship among vitamin D metabolism, true calcium absorption, parathyroid function, and age in women: evidence of an age-related intestinal resistance to 1,25-dihydroxyvitamin D action. J Bone Miner Res 6:125–132CrossRefPubMedGoogle Scholar
  50. Ensrud KE, Ewing SK, Fredman L et al (2010) Circulating 25- hydroxyvitamin D levels and frailty status in older women. J Clin Endocrinol Metab 95:5266–5273CrossRefPubMedPubMedCentralGoogle Scholar
  51. Epstein S, Bryce G, Hinman JW et al (1986) The influence of age on bone mineral regulating hormones. Bone 7:421–425CrossRefPubMedGoogle Scholar
  52. Formiga F, Ferrer A, Almeda J et al (2011) Utility of geriatric assessment tools to identify 85- years old subjects with vitamin D deficiency. J Nutr Health Aging 15:110–114CrossRefPubMedGoogle Scholar
  53. Francis RM (2007) The vitamin D paradox. Rheumatol (Oxf) 46(12):1749–1750CrossRefGoogle Scholar
  54. Francis RM, Peacock M, Storer JH et al (1983) Calcium malabsorption in the elderly: the effect of treatment with oral 25-hydroxyvitamin D3. Eur J Clin Investig 13:391–396CrossRefGoogle Scholar
  55. Francis RM, Peacock M, Barkworth SA (1984) Renal impairment and its effects on calcium metabolism in elderly women. Age Ageing 13:14–20CrossRefPubMedGoogle Scholar
  56. Gallagher JC, Yalamanchili V, Smith LM (2012) The effect of vitamin D on calcium absorption in older women. J Clin Endocrinol Metab 97:3550–3556CrossRefPubMedPubMedCentralGoogle Scholar
  57. Girgis CM, Clifton-Bligh RJ, Hamrick MW et al (2013) The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocr Rev 34:33–83CrossRefPubMedGoogle Scholar
  58. Granic A, Aspray T, Hill T et al (2015a) 25-hydroxyvitamin D and increased all-cause mortality in very old women: the Newcastle 85+ study. J Intern Med 277:456–467CrossRefPubMedGoogle Scholar
  59. Granic A, Hill TR, Kirkwood TB et al (2015b) Circulating 25-hydroxyvitamin D and cognitive decline in the very old: the Newcastle 85+ study. Eur J Neurol 22:106–115CrossRefPubMedGoogle Scholar
  60. Granic A, Davies K, Jagger C et al (2016) Grip strength decline and its determinants in the very old: longitudinal findings from the Newcastle 85+ study. PLoS One 11:e0163183CrossRefPubMedPubMedCentralGoogle Scholar
  61. Granic A, Hill TR, Davies K et al (2017) Vitamin D status, muscle strength and physical performance decline in very old adults: a prospective study. Nutrients 9(4):379CrossRefPubMedCentralGoogle Scholar
  62. Grant AM, Avenell A, Campbell MK et al (2005) Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (randomised evaluation of calcium or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 365:1621–1628CrossRefPubMedGoogle Scholar
  63. Gunnarsson O, Indridason OS, Franzson L, Sigurdsson G (2009) Factors associated with elevated or blunted PTH response in vitamin D insufficient adults. J Int Med 265(4):488–495CrossRefGoogle Scholar
  64. Hansen AL, Dahl L, Bakke L, Thayer JF (2011) Vitamin D and executive function: a preliminary report. Percept Mot Skills 113:667–685CrossRefGoogle Scholar
  65. Health Survey for England (2008) Physical activity and fitness. National Centre for Social Research. Retrieved from http://www.hscic.gov.uk/pubs/hse08physicalactivity Google Scholar
  66. Heaney RP, Holick MF (2011) Why the IOM recommendations for vitamin D are deficient. J Bone Miner Res 26(3):455–457CrossRefPubMedGoogle Scholar
  67. Heaney RP, Recker RR, Stegman MR, Moy AJ (1989) Calcium absorption in women: relationships to calcium intake, estrogen status, and age. J Bone Miner Res 4:469–475CrossRefPubMedGoogle Scholar
  68. Hill TR, O’Brien MM, Cashman KD et al (2004) Vitamin D intakes in 18–64 year-old Irish adults. Eur J Clin Nutr 58:1509–1517CrossRefPubMedGoogle Scholar
  69. Hill TR, Granic A, Davies K et al (2016) Circulating 25-hydroxyvitamin D concentration and its determinants in the very old: the Newcastle 85+ study. Osteoporos Int 27:1199–1208CrossRefPubMedGoogle Scholar
  70. Hirani V, Primatesta P (2005) Vitamin D concentrations among people aged 65 years and over living in private households and institutions in England: population study. Age Ageing 34:485–491CrossRefPubMedGoogle Scholar
  71. Holick MF (1994) McCollum award lecture: vitamin D – new horizons for the 21st century. Am J Clin Nutr 60:619–630CrossRefPubMedGoogle Scholar
  72. Holick MF (2003) Evolution and function of vitamin D. Recent Results Cancer Res 164:3–28CrossRefPubMedGoogle Scholar
  73. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266–281CrossRefPubMedGoogle Scholar
  74. Holick MF (2008) Vitamin D: a D-lightful health perspective. Nutr Rev 66:S182–S194CrossRefPubMedGoogle Scholar
  75. Holick MF, Matsuoka LY, Wortsman J (1989) Age, vitamin D, and solar ultraviolet. Lancet 2(8671):1104–1105CrossRefPubMedGoogle Scholar
  76. Horst RL, Reinhardt TA (1997) Vitamin D metabolism. In: Feldman D, Glorieux FH, Pike JW (eds) Vitamin D. Academic, San Diego, pp 13–31Google Scholar
  77. Hossein-Nezhad A, Holick MF (2013) Vitamin D for health: a global perspective. Mayo Clin Proc 88:720–755CrossRefPubMedPubMedCentralGoogle Scholar
  78. Houston DK (2015) Vitamin D and age-related health outcomes: movement, mood, and memory. Curr Nutr Rep 4:185–200CrossRefPubMedPubMedCentralGoogle Scholar
  79. Houston DK, Tooze JA, Davis CC et al (2011a) Circulating 25-hydroxyvitamin D and physical function in older adults: the cardiovascular health study all stars. J Am Geriatr Soc 59:1793–1801CrossRefPubMedPubMedCentralGoogle Scholar
  80. Houston DK, Tooze JA, Hausman DB et al (2011b) Change in 25-hydroxyvitamin D and physical performance in older adults. J Gerontol A Biol Sci Med Sci 66(4):430–436CrossRefPubMedGoogle Scholar
  81. Houston DK, Tooze JA, Neiberg RH et al (2012) Health ABC Study. 25-hydroxyvitamin D status and change in physical performance and strength in older adults: the health, aging, and body composition study. Am J Epidemiol 176:1025–1034CrossRefPubMedPubMedCentralGoogle Scholar
  82. Ibi M, Sawada H, Nakanishi M et al (2001) Protective effect of 1 alpha,25-(OH)(2)D-3 against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture. Neuropharmacology 40:761–771CrossRefPubMedGoogle Scholar
  83. Institute of Medicine (1997) Dietary reference intakes. For calcium, phosphorus, magnesium, vitamin D and fluoride. In: Food and nutrition board. National Academy Press, Washington, DC, pp 1–448Google Scholar
  84. International Agency for Research on Cancer (IARC) (2008) Vitamin D and cancer/a report of the IARC working group on Vitamin D. IARC, LyonGoogle Scholar
  85. Ireland P, Fordtran JS (1973) Effect of dietary calcium and age on jejunal calcium absorption in humans studied by intestinal perfusion. J Clin Invest 52:2672–2681CrossRefPubMedPubMedCentralGoogle Scholar
  86. Jackson RD, LaCroix AZ, Gass M et al (2006) Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 354:669–683CrossRefPubMedGoogle Scholar
  87. Johansson P, Almqvist EG, Johansson J-O et al (2013) Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer’s disease. PLoS One 8:e81989CrossRefPubMedPubMedCentralGoogle Scholar
  88. Kempen GI, Ranchor AV, van Sonderen E et al (2006) Risk and protective factors of different functional trajectories in older persons: are these the same? J Gerontol B Psychol Sci Soc Sci 61:95–101CrossRefGoogle Scholar
  89. Kesby JP, Eyles DW, Burne THJ et al (2011) The effects of vitamin D on brain development and adult brain function. Mol Cell Endocrinol 347:121–127CrossRefPubMedGoogle Scholar
  90. Kiely M, Black L (2012) Dietary strategies to maintain adequacy of circulating 25-hydroxyvitamin D concentrations. Scand J Clin Lab Invest 72(Suppl):14–23Google Scholar
  91. Kingston A, Davies K, Collerton J et al (2014) The contribution of diseases to the male-female disability-survival paradox in the very old: results from the Newcastle 85+ study. PLoS One 9:e88016CrossRefPubMedPubMedCentralGoogle Scholar
  92. Krejs GJ, Nicar MJ, Zerwekh JE et al (1983) Effect of 1,25-dihydroxyvitamin D3 on calcium and magnesium absorption in the healthy human jejunum and ileum. Am J Med 75(6):973–976CrossRefPubMedGoogle Scholar
  93. LaCroix AZ, Kotchen J, Anderson G et al (2009) Calcium plus vitamin D supplementation and mortality in postmeno- pausal women: the Women Health Initiative calcium-vita- min D randomized controlled trial. J Gerontol A Biol Sci Med Sci 64:559–567CrossRefPubMedGoogle Scholar
  94. Lai JK, Lucas RM, Banks E et al (2012) Variability in vitamin D assays impairs clinical assessment of vitamin D status. Int Med J 42(1):43–50CrossRefGoogle Scholar
  95. Lal H, Pandey R, Aggarwal SK (1999) Vitamin D: non-skeletal actions and effects on growth. Nutr Res 19:1683–1718CrossRefGoogle Scholar
  96. Lanham-New SA, Buttriss JL, Miles LM et al (2011) Proceedings of the rank forum on vitamin D. Br J Nutr 105(1):144–156CrossRefPubMedGoogle Scholar
  97. Lappe JM, Davies KM, Travers-Gustafson D, Heaney RP (2006) Vitamin D status in a rural postmenopausal female population. J Am Coll Nutr 25(5):395–402CrossRefPubMedGoogle Scholar
  98. Law M, Withers H, Morris J, Anderson F (2006) Vitamin D supplementation and the prevention of fractures and falls: results of a randomised trial in elderly people in residential accommodation. Age Ageing 35(5):482–486CrossRefPubMedGoogle Scholar
  99. Lee DM, Tajar A, Ulubaev A et al (2009) Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged older European men. J Neurol Neurosurg Psychiatry 80:722–729CrossRefPubMedGoogle Scholar
  100. Lips P, Chapuy MC, Dawson-Hughes B et al (1999) An international comparison of circulating 25-hydroxyvitamin D measurements. Osteoporos Int 9(5):394–397CrossRefPubMedGoogle Scholar
  101. Lips P, Hosking D, Lippuner K et al (2006) The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Int Med 260:245–254CrossRefGoogle Scholar
  102. Llewellyn DJ, Lang IA, Langa KM et al (2010) Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med 170:1135–1141CrossRefPubMedPubMedCentralGoogle Scholar
  103. Llewellyn DJ, Lang IA, Langa KM, Melzer D (2011) Vitamin D and cognitive impairment in the elderly U.S. population. J Gerontol A Biol Sci Med Sci 66:59–65CrossRefPubMedGoogle Scholar
  104. MacLaughlin J, Holick MF (1985) Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 76(4):1536–1538CrossRefPubMedPubMedCentralGoogle Scholar
  105. Martin TJ, Seeman E (2008) Bone remodelling: its local regulation and the emergence of bone fragility. Best Pract Res Clin Endocrinol Metab 22(5):701–722CrossRefPubMedGoogle Scholar
  106. Matheï C, Van Pottelbergh G, Vaes B et al (2013) No relation between vitamin D status and physical performance in the oldest old: results from the Belfrail study. Age Ageing 42(2):186–190CrossRefPubMedGoogle Scholar
  107. Matsuoka LY, Wortsman J, Dannenberg MJ et al (1992) Clothing prevents ultraviolet-B radiation-dependent photosynthesis of vitamin D3. J Clin Endocrinol Metab 75:109–103Google Scholar
  108. McCarthy EK, Kiely M (2015) Vitamin D and muscle strength throughout the life course: a review of epidemiological and intervention studies. J Hum Nutr Diet 28:636–645CrossRefPubMedGoogle Scholar
  109. McGrath J, Scragg R, Chant D et al (2007) No association between circulating 25-hydroxyvitamin D3 levels and performance on psychometric tests in NHANES III. Neuroepidemiology 29:49–54CrossRefPubMedGoogle Scholar
  110. Melamed ML, Michos ED, Post W, Astor B (2008) 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168:1629–1637CrossRefPubMedPubMedCentralGoogle Scholar
  111. Menant JC, Close JC, Delbaere K et al (2012) Relationship between circulating vitamin D levels, neuromuscular and neuropsychological function and falls in older men and women. Osteoporos Int 23:981–989CrossRefPubMedGoogle Scholar
  112. Michae€lsson K, Baron JA, Snellman G et al (2010) Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am J Clin Nutr 92:841–848CrossRefPubMedGoogle Scholar
  113. Mithal A, Wahl DA, Bonjour JP et al (2009) Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 20(11):1807–1820CrossRefPubMedGoogle Scholar
  114. Murad MH, Elamin KB, Abu Elnour NO et al (2011) The effect of vitamin D on falls: a systematic review and meta-analysis. J Clin Endocrinol Metab 96:2997–3006CrossRefPubMedGoogle Scholar
  115. Neuhouser ML, Wassertheil-Smoller S, Thomson C et al (2009) Multivitamin use and risk of cancer and cardiovascular disease in the Women’s Health Initiative cohorts. Arch Intern Med 169:294–304CrossRefPubMedGoogle Scholar
  116. Olsson K, Saini A, Strömberg A et al (2016) Evidence for vitamin D receptor expression and direct effects of 1α,25(OH)2D3 in human skeletal muscle precursor cells. Endocrinology 157:98–111CrossRefPubMedGoogle Scholar
  117. Ovesen L, Andersen R, Jakobsen J (2003) Geographical differences in vitamin D status, with particular reference to European countries. Proc Nutr Soc 62:813–821CrossRefPubMedGoogle Scholar
  118. Patel JV, Chackathayil J, Hughes EA et al (2013) Vitamin D deficiency amongst minority ethnic groups in the UK: a cross sectional study. Int J Cardiol 67(5):2172–2176CrossRefGoogle Scholar
  119. Perna L, Haug U, Schöttker B et al (2012) Public health implications of standardized 25-hydroxyvitamin D levels: a decrease in the prevalence of vitamin D deficiency among older women in Germany. Prev Med 55:228–232CrossRefPubMedGoogle Scholar
  120. Pludowski P, Holick MF, Pilz S et al (2013) Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun Rev 12:976–989CrossRefPubMedGoogle Scholar
  121. Prentice A, Goldberg G, Schoenmakers I (2008) Vitmain D across the lifecycle: physiology and biomarkers. Am J Clin Nutr 88(2):500S–505SCrossRefPubMedGoogle Scholar
  122. Priemel M, von Domarus C, Klatte TO et al (2010) Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Min Res 25(2):305–312CrossRefGoogle Scholar
  123. Reid D, Toole BJ, Knox S et al (2011) The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. Am J Clin Nutr 93:1006–1011CrossRefPubMedGoogle Scholar
  124. Rejnmark L (2011) Effects of vitamin d on muscle function and performance: a review of evidence from randomized controlled trials. Ther Adv Chronic Dis 2:25–37CrossRefPubMedPubMedCentralGoogle Scholar
  125. Rejnmark L, Vestergaard P, Heickendorff L, Mosekilde L (2011) Determinants of plasma PTH and their implication for defining a reference interval. Clin Endocrinol 74(1):37–43CrossRefGoogle Scholar
  126. Rosen CJ, Abrams SA, Aloia JF et al (2012) IOM Committee members response to Endocrine Society vitamin D guidelines. J Clin Endocrinol Metab 97:1146–1152CrossRefPubMedPubMedCentralGoogle Scholar
  127. Ross C, Abrams S, Aloia JF et al. (2010) Institute of Medicine. Dietary reference intakes for calcium and vitamin D. National Academies Press, Washington, DCGoogle Scholar
  128. Rowan E, McKeith IG, Saxby BK et al (2007) Effects of donepezil on central processing speed and attentional measures in Parkinson’s disease with dementia and dementia with Lewy bodies. Dement Geriatr Cogn Disord 23:161–167CrossRefPubMedGoogle Scholar
  129. Rush L, McCartney G, Walsh D, MacKay D (2013) Vitamin D and subsequent all-age and premature mortality: a systematic review. BMC Public Health 13:679CrossRefPubMedPubMedCentralGoogle Scholar
  130. Sahota O, Gaynor K, Harwood RH, Hosking DJ (2001) Hypovitaminosis D and ‘functional hypoparathyroidism’-the NoNoF (Nottingham Neck of Femur) study. Age Ageing 30(6):467–472CrossRefPubMedGoogle Scholar
  131. Sahota O, Mundey MK, San P et al (2004) The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Bone 35(1):312–319CrossRefPubMedGoogle Scholar
  132. Sahota O, Mundey MK, San P et al (2006) Vitamin D insufficiency and the blunted PTH response in established osteoporosis: the role of magnesium deficiency. Osteoporos Int 17(7):1013–1021CrossRefPubMedGoogle Scholar
  133. Sanders KM, Stuart AL, Williamson EJ et al (2010) Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 303:1815–1822CrossRefPubMedGoogle Scholar
  134. Sanders KM, Nicholson GC, Ebeling PR (2013) Is high dose vitamin D harmful? Calcif Tissue Int 92:191–206CrossRefPubMedGoogle Scholar
  135. SchÖttker B, Ball D, Gellert C, Brenner H (2013) Circulating 25-hydroxyvitamin D levels and overall mortality. A systematic review and meta-analysis of prospective cohort studies. Ageing Res Rev 12:708–718CrossRefPubMedGoogle Scholar
  136. Scragg R (2011) Vitamin D and public health: an overview of recent research on common diseases and mortality in adulthood. Public Health Nutr 14:1515–1532CrossRefPubMedGoogle Scholar
  137. Seamans KM, Hill TR, Scully L et al (2010) Vitamin D status and measures of cognitive function in healthy older European adults. Eur J Clin Nutr 64:1172–1178CrossRefPubMedGoogle Scholar
  138. Shoben AB, Kestenbaum B, Levin G et al (2011) Seasonal variation in 25-hydroxyvitamin D concentrations in the cardiovascular health study. Am J Epidemiol 174:1363–1372CrossRefPubMedPubMedCentralGoogle Scholar
  139. Siervo M, Prado C, Hooper L et al (2015) Circulating osmolarity and haematocrit do not modify the association between the impedance index (Ht2/Z) and total body water in the very old: the Newcastle 85+ study. Arch Gerontol Geriatr 60:227–232CrossRefPubMedGoogle Scholar
  140. Signorello LB, Han X, Cai Q et al (2013) A prospective study of circulating 25-hydroxyvitamin D levels and mortality among African Americans and non-African Americans. Am J Epidemiol 177:171–179CrossRefPubMedGoogle Scholar
  141. Simpson RU, Thomas GA, Arnold AJ (1985) Identification of 1,25- dihydroxyvitamin D3 receptors and activities in muscle. J Biol Chem 260:8882–8891PubMedGoogle Scholar
  142. Singh KP, Dash RJ (1997) Vitamin D endocrine system. J Assoc Phys India 45:559–568Google Scholar
  143. Slinin Y, Paudel ML, Taylor BC et al (2010) 25-Hydroxyvita- min D levels and cognitive performance and decline in elderly men. Neurology 74:33–41CrossRefPubMedPubMedCentralGoogle Scholar
  144. Slinin Y, Paudel M, Taylor BC et al (2012) Association between circulating 25(OH) vitamin D and the risk of cognitive decline in older women. J Gerontol A Biol Sci Med Sci 67:1092–1098CrossRefPubMedPubMedCentralGoogle Scholar
  145. Smit E, Crespo CJ, Michael Y et al (2012) The effect of vitamin D and frailty on mortality among non-institutionalized US older adults. Eur J Clin Nutr 66:1024–1028CrossRefPubMedGoogle Scholar
  146. Smith H, Anderson F, Raphael H et al (2007) Effect of annual intramuscular vitamin D on fracture risk in elderly men and women – a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford) 46:1852–1857CrossRefGoogle Scholar
  147. Snellman G, Melhus H, Gedeborg R et al (2010) Determining vitamin D status: a comparison between commercially available assays. PLoS One 5:e11555CrossRefPubMedPubMedCentralGoogle Scholar
  148. Sohl E, van Schoor NM, de Jongh RT et al (2012) The impact of medication on vitamin D status in older individuals. Eur J Endocrinol 166:477–485CrossRefPubMedGoogle Scholar
  149. Sohl E, van Schoor NM, de Jongh RT et al (2013a) Vitamin D status is associated with functional limitations and functional decline in older individuals. J Clin Endocrinol Metab 98:E1483–E1490CrossRefPubMedGoogle Scholar
  150. Sohl E, de Jongh RT, Heijboer AC et al (2013b) Vitamin D status is associated with physical performance: the results of three independent cohorts. Osteoporos Int 24:187–196CrossRefPubMedGoogle Scholar
  151. The Scientific Advisory Committee on Nutrition (2016) Vitamin D and health. https://www.gov.uk/government/groups/scientific-advisory-committee-on-nutrition
  152. Theoleyre S, Wittrant Y, Tat SK et al (2004) The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev 15(6):457–475CrossRefPubMedGoogle Scholar
  153. Turner AG, Anderson PH, Morris HA (2012) Vitamin D and bone health. Scand J Clin Lab Invest Suppl 243:65–72PubMedGoogle Scholar
  154. Van der Wielen RPJ, Lowik MRH, Van Den Berg H et al (1995) Circulating vitamin D concentrations among elderly people in Europe. Lancet 346:207–210CrossRefPubMedGoogle Scholar
  155. Verreault R, Semba RD, Volpato S et al (2002) Low circulating vitamin d does not predict new disability or loss of muscle strength in older women. J Am Geriatr Soc 50:912–917CrossRefPubMedGoogle Scholar
  156. Vieth R, Ladak Y, Walfish PG (2003) Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. J Clin Endocrinol Metab 88:185–191CrossRefPubMedGoogle Scholar
  157. Wahl DA, Cooper C, Ebeling PR et al (2012) A global representation of vitamin D status in healthy populations. Arch Osteoporos 7(1–2):155–172CrossRefPubMedGoogle Scholar
  158. Waldron JL, Ashby HL, Cornes MP et al (2013) Vitamin D: a negative acute phase reactant. J Clin Pathol 66:620–622CrossRefPubMedGoogle Scholar
  159. Wang S (2009) Epidemiology of vitamin D in health and disease. Nutr Res Rev 22:188–203CrossRefPubMedGoogle Scholar
  160. Wang Y, DeLuca HF (2011) Is the vitamin D receptor found in muscle? Endocrinology 152:354–363CrossRefPubMedGoogle Scholar
  161. Wang Y, Jacobs EJ, McCullough ML et al (2009) Comparing methods for accounting for seasonal variability in a bio- marker when only a single sample is available: insights from simulation based on circulating 25-hydroxyvitamin D. Am J Epidemiol 170:88–94CrossRefPubMedGoogle Scholar
  162. Webb AR, Kline L, Holick MF (1988) Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 67:373–378CrossRefPubMedGoogle Scholar
  163. Welsh J (2012) Cellular and molecular effects of vitamin D on carcinogenesis. Arch Biochem Biophys 523:107–114CrossRefPubMedGoogle Scholar
  164. Wesnes KA (2008) Assessing change in cognitive function in dementia: the relative utilities of the Alzheimer’s disease assessment scale-cognitive subscale and the cognitive drug research system. Neurodegener Dis 5(3–4):261–263CrossRefPubMedGoogle Scholar
  165. Wesnes KA, Ward T, McGinty A, Petrini O (2000) The memory enhancing effects of a Ginko biloba/Panax ginseng combination in healthy middle-aged volunteers. Psycho-pharmacology 152:353–361CrossRefGoogle Scholar
  166. White JH (2012) Vitamin D metabolism and signalling in the immune system. Rev Endocr Metab Disord 13(1):21–29CrossRefPubMedGoogle Scholar
  167. Wicherts IS, van Schoor NM, Boeke AJ et al (2007) Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab 92:2058–2065CrossRefPubMedGoogle Scholar
  168. Wilson VK, Houston DK, Kilpatrick L et al (2014) Relationship between 25-hydroxyvitamin D and cognitive function in older adults: the health, aging and body composition study. J Am Geriatr Soc 62:636–641CrossRefPubMedPubMedCentralGoogle Scholar
  169. Zittermann A, Iodice S, Pilz S et al (2012) Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr 95:91–100CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  • Tom R. Hill
    • 1
    • 2
    • 3
    Email author
  • Antoneta Granic
    • 4
    • 3
    • 5
  • Terence J. Aspray
    • 2
    • 6
    • 3
    • 5
  1. 1.Human Nutrition Research CentreNewcastle UniversityNewcastle Upon TyneUK
  2. 2.Institute of Cellular MedicineNewcastle UniversityNewcastle Upon TyneUK
  3. 3.Institute of AgeingNewcastle UniversityNewcastle Upon TyneUK
  4. 4.Institute of NeuroscienceNewcastle UniversityNewcastle Upon TyneUK
  5. 5.NIHR Newcastle Biomedical Research Centre, Newcastle upon Tyne Hospitals NHS Foundation TrustNewcastle UniversityNewcastle Upon TyneUK
  6. 6.The Bone Clinic, Freeman HospitalNewcastle Upon TyneUK

Personalised recommendations